Back to results
US 2022/0008522 A1Published application
Immunosuppressive antigen-specific chimeric antigen receptor treg cells for prevention and/or treatment of autoimmune and alloimmune disorders
AssigneeThe University of Toledo
InventorsJuan C. Jaume, Shahnawaz Imam
Life of this patent
Estimating the term…
Abstract
Described herein are immunoresponsive cells which are useful for their preventive and therapeutic potential against autoimmune diseases and rejections of solid organ transplants.
Claims24
An immunoresponses cell comprising:
- a chimeric antigen receptor (CAR) that binds to glutamic acid decarboxylase 65 kDA (GAD65) in the cell;
- the CAR comprising:
- a) an intracellular signaling domain of a CD3ξ polypeptide and an intracellular signaling domain of CD28 hinge-transmembrane-intracellular region, and
- b) an extracellular polypeptide recognizing:
- at least a part of an amino acid sequence selected from the amino acids having SEQ ID Nos:
- 1-6;
- or, at least one complete amino acid sequence selected from the amino acids having SEQ ID Nos:
- 1-6.
5 more elements
(canceled)
11-13. (canceled)
15-39. (canceled)
Dependencies are inferred from the claim text.